2758802-10-5
Chemical Structure
HSD17B13-IN-17
- CAS No.: 2758802-10-5
- Formula:C20H16ClFN2O3S
- Molecular Weight:418.87
InChIKey: RPRXCKYWWGUQGM-UHFFFAOYSA-N
SMILES: OC1=C(Cl)C=C(C(NC2=C(C(NCCC3=C(F)C=CC=C3)=O)SC=C2)=O)C=C1
Biological Activity: HSD17B13-IN-17 (compound 9) is a ppotent inhibitor of hydroxysteroid 17?-dehydrogenase 13 (HSD17B13), with the IC50 of < 0.1 μM and? < 1 μM estradiol and Leukotriene B3 as substrates, respectively. HSD17B13-IN-17? plays an important role in nonalcoholic fatty liver diseases (NAFLDs) including NASH (nonalcoholic steatohepatitis)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HSD17B13-IN-17 | HSD17B13-IN-17 (compound 9) is a ppotent inhibitor of hydroxysteroid 17?-dehydrogenase 13 (HSD17B13), with the IC50 of < 0.1 μM and? < 1 μM estradiol and Leukotriene B3 as substrates, respectively. HSD17B13-IN-17? plays an important role in nonalcoholic fatty liver diseases (NAFLDs) including NASH (nonalcoholic steatohepatitis). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords